Morpheus®
Biogennix’s flagship product brand, Morpheus, is an advanced bone graft product consisting of a moldable suspension of 1-2mm TrelCor granules in a rapidly absorbing, organic binder. Based on TrelCor technology, the granules provide enhanced bone formation due to the combination of a nanocrystalline surface with an HCA composition and interconnected pore structure that emulate human cancellous bone.
Morpheus bone graft product is a robust graft material that provides optimal handling characteristics during intraoperative placement. Morpheus is moldable, cohesive, mixable with autogenous bone, and leaves minimal residual material on surgical gloves following handling. The binder’s resistance to breakdown and irrigation facilitate secure placement and stabilization of the graft mass. It is then rapidly absorbed leaving behind the porous TrelCor granules, which are resorbed, remodeled, and replaced with bone over the next 6-12 months.
Configuration: Moldable
Chemistry: Nanocrystalline hydroxycarbanoapatite (HCA) / calcium carbonate (CC) granules in organic binder
Architecture: Biomimetic structure similar to cancellous bone; interconnected porosity
Granule Pore Size: 500 microns (µm)
Binder Absorption Profile: 1-2 days
Granule Resorption Profile: 6-12 months
Storage and Handling: Room temperature, no reconstitution required
